Table 3. Comparison of Levels of Serum and Urine Nephrin between Normal and Subsequent PE Patients.
| Control (n=68) | PE (n=12) | p value* | |
|---|---|---|---|
| Serum nephrin (ng/mL) | |||
| <15 wks | 82.91 (39.90–189.50) | 80.48 (55.71–108.99) | 0.80 |
| 16–20 wks | 84.08 (27.79–225.60) | 88.35 (69.25–200.30) | 0.20 |
| 21–28 wks | 73.15 (21.57–226.92) | 145.64 (58.68–210.42) | <0.001 |
| 29–40 wks | 70.00 (18.07–142.66) | 100.60 (73.30–131.41) | <0.001 |
| Urine nephrin (ng/mL) | |||
| <15 wks | 0.08 (0.01–1.03) | 0.10 (0.01–0.30) | 0.49 |
| 16–20 wks | 0.11 (0.01–0.85) | 0.26 (0.10–0.53) | 0.33 |
| 21–28 wks | 0.17 (0.01–1.03) | 0.23 (0.09–0.99) | 0.78 |
| 29–40 wks | 0.19 (0.01–1.17) | 2.11 (0.85–2.86) | <0.001 |
PE, preeclampsia.
Values are expressed as median (range).
*p-value by Mann-Whitney U test.